These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 8831111

  • 1. S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.
    Newman-Tancredi A, Chaput C, Verrièle L, Millan MJ.
    Eur J Pharmacol; 1996 Jun 20; 307(1):107-11. PubMed ID: 8831111
    [Abstract] [Full Text] [Related]

  • 2. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
    Newman-Tancredi A, Conte C, Chaput C, Verrièle L, Audinot-Bouchez V, Lochon S, Lavielle G, Millan MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun 20; 355(6):682-8. PubMed ID: 9205951
    [Abstract] [Full Text] [Related]

  • 3. Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
    Jerning E, Rosqvist S, Mohell N.
    J Recept Signal Transduct Res; 2002 Jun 20; 22(1-4):483-95. PubMed ID: 12503636
    [Abstract] [Full Text] [Related]

  • 4. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
    Newman-Tancredi A, Verrièle L, Chaput C, Millan MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar 20; 357(3):205-17. PubMed ID: 9550290
    [Abstract] [Full Text] [Related]

  • 5. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E, Li H, Carr KD, Hiller JM.
    J Pharmacol Exp Ther; 2000 Feb 20; 292(2):684-91. PubMed ID: 10640306
    [Abstract] [Full Text] [Related]

  • 6. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.
    Alper RH, Nelson DL.
    Eur J Pharmacol; 1998 Feb 19; 343(2-3):303-12. PubMed ID: 9570480
    [Abstract] [Full Text] [Related]

  • 7. Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry.
    Newman-Tancredi A, Conte C, Chaput C, Verrièle L, Millan MJ.
    Neuropharmacology; 1997 Feb 19; 36(4-5):451-9. PubMed ID: 9225269
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635.
    Newman-Tancredi A, Conte C, Chaput C, Spedding M, Millan MJ.
    Br J Pharmacol; 1997 Mar 19; 120(5):737-9. PubMed ID: 9138675
    [Abstract] [Full Text] [Related]

  • 9. The putative <<silent>> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
    Cosi C, Koek W.
    Eur J Pharmacol; 2000 Jul 28; 401(1):9-15. PubMed ID: 10915831
    [Abstract] [Full Text] [Related]

  • 10. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724
    [Abstract] [Full Text] [Related]

  • 11. The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study.
    Newman-Tancredi A, Rivet J, Chaput C, Touzard M, Verrièle L, Millan MJ.
    Eur J Pharmacol; 1999 Nov 19; 384(2-3):111-21. PubMed ID: 10611431
    [Abstract] [Full Text] [Related]

  • 12. Aging alters in a region-specific manner serotonin transporter sites and 5-HT(1A) receptor-G protein interactions in hamster brain.
    Duncan MJ, Hensler JG.
    Neuropharmacology; 2002 Jul 19; 43(1):36-44. PubMed ID: 12213257
    [Abstract] [Full Text] [Related]

  • 13. Stimulated [35S]GTP gamma S binding by 5-HT1A receptor agonists in recombinant cell lines. Modulation of apparent efficacy by G-protein activation state.
    Pauwels PJ, Tardif S, Wurch T, Colpaert FC.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov 19; 356(5):551-61. PubMed ID: 9402034
    [Abstract] [Full Text] [Related]

  • 14. Autoradiographic studies of 5-HT1A-receptor-stimulated [35S]GTPgammaS-binding responses in the human and monkey brain.
    Dupuis DS, Pauwels PJ, Radu D, Hall H.
    Eur J Neurosci; 1999 May 19; 11(5):1809-17. PubMed ID: 10215933
    [Abstract] [Full Text] [Related]

  • 15. In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
    Jordan S, Chen R, Koprivica V, Hamilton R, Whitehead RE, Tottori K, Kikuchi T.
    Eur J Pharmacol; 2005 Jul 11; 517(3):165-73. PubMed ID: 15985260
    [Abstract] [Full Text] [Related]

  • 16. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
    Watson J, Roberts C, Scott C, Kendall I, Collin L, Day NC, Harries MH, Soffin E, Davies CH, Randall AD, Heightman T, Gaster L, Wyman P, Parker C, Price GW, Middlemiss DN.
    Br J Pharmacol; 2001 Jul 11; 133(6):797-806. PubMed ID: 11454652
    [Abstract] [Full Text] [Related]

  • 17. Characterisation of a cloned human 5-HT1A receptor cell line using [35S]GTP gamma S binding.
    Stanton JA, Beer MS.
    Eur J Pharmacol; 1997 Feb 12; 320(2-3):267-75. PubMed ID: 9059863
    [Abstract] [Full Text] [Related]

  • 18. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS, Colpaert FC, Pauwels PJ.
    Br J Pharmacol; 1998 May 12; 124(2):283-90. PubMed ID: 9641544
    [Abstract] [Full Text] [Related]

  • 19. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A, Verrièle L, Millan MJ.
    Br J Pharmacol; 2001 Jan 12; 132(2):518-24. PubMed ID: 11159702
    [Abstract] [Full Text] [Related]

  • 20. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ.
    J Pharmacol Exp Ther; 1997 Mar 12; 280(3):1241-9. PubMed ID: 9067310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.